Q2 2018 Holdings
Filed 2018-08-14 | 16 holdings | $8.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adaptimmune(ADAPY) | SPONDS ADR | 00653A107 | $3.0M | 250,000 | 36.1% |
| Cellectis(CLLS) | SPONDS ADR | 15117K103 | $2.8M | 100,000 | 34.4% |
| Aurinia Pharma(AUPH) | Common | 05156V102 | $2.3M | 400,434 | 27.4% |
| Crispr(CRSP) | NAMEN AKT | H17182108 | $72.7K | 1,237,202 | 0.9% |
| Sientra | Common | 82621J105 | $48.3K | 2,480,494 | 0.6% |
| Paratek | Common | 699374302 | $10.6K | 1,041,131 | 0.1% |
| Obseva | Common | H5861P103 | $6.7K | 440,000 | 0.1% |
| GTX | Common | 40052B207 | $5.2K | 339,174 | 0.1% |
| Proteon | Common | 74371L109 | $4.8K | 2,017,872 | 0.1% |
| Sierra Oncology | Common | 82640U107 | $4.3K | 1,444,445 | 0.1% |
| Cymabay(CBAYUSD) | Common | 23257D103 | $3.7K | 273,417 | 0.0% |
| Chiasma(CHMA) | Common | 16706W102 | $3.1K | 2,080,595 | 0.0% |
| Ultragenyx(RARE) | Common | 90400D108 | $2.9K | 38,100 | 0.0% |
| Histogenix | Common | 43358V109 | $2.2K | 888,889 | 0.0% |
| Immune Design | Common | 45252L103 | $1.6K | 352,300 | 0.0% |
| Aveo Pharma(AVEOEUR) | Common | 053588109 | $900 | 400,000 | 0.0% |